Related Experiment Video
Updated: May 13, 2026
20:28
A Toolkit to Enable Hydrocarbon Conversion in Aqueous Environments
Published on: October 2, 2012
[Butanol pathway construction and promoter optimization in Escherichia coli]
1Key Laboratory of Synthetic Biology, Institute of Plant Physiology and Ecology, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences, Shanghai 200032, China.
Summary
Optimizing promoters in synthetic biology enhances gene overexpression. This study improved butanol production in E. coli by fusing the thlA gene and operon with specific promoters, achieving a 3-5 fold increase.
Area of Science:
- Synthetic biology
- Metabolic engineering
- Biotechnology
Background:
- Butanol is a valuable chemical intermediate and solvent.
- Escherichia coli is a common host for metabolic engineering.
- Promoter optimization is underexplored for butanol production in E. coli.
Purpose of the Study:
- To optimize promoter strength for enhanced butanol production.
- To investigate the effect of promoter fusion on thlA gene and operon expression.
- To improve butanol yield in a non-native host.
Main Methods:
- Gene fusion of thlA (thiolase) and operon with different promoters (Alper PLTetO1, Alper BB, Braatsch 20, Braatsch 10).
- Utilized the DNA assembler method for fast gene assembly.
- Cultivated engineered Escherichia coli strains for butanol production.
Main Results:
- The fusion of thlA with the strong promoter Alper PLTetO1 and the operon with the weak promoter Braatsch 10 yielded the highest butanol concentration.
- Achieved a peak butanol concentration of 28 mg/L.
- Demonstrated a 3-5 fold increase in butanol concentration compared to other promoter combinations.
Conclusions:
- Strategic promoter selection and fusion are critical for optimizing metabolic pathways.
- This promoter optimization strategy significantly enhances butanol production in Escherichia coli.
- The identified promoter combinations offer a promising approach for industrial butanol synthesis.
Related Concept Videos
01:30Production of Pharmaceuticals
Industrial insulin production uses genetically engineered E. coli expressing a proinsulin gene controlled by a tryptophan promoter and containing a methionine linker for later cleavage. The cells also carry ampicillin resistance for selective growth. Seed cultures are stored at −80 °C and production begins by thawing a small amount to inoculate starter cultures, which are progressively scaled to a 50,000-L bioreactor. In the bioreactor, E. coli grow in nutrient-rich media under sterile, tightly...
01:22Bioreactor Controls-III
Strain improvement is a foundational strategy in industrial microbiology aimed at maximizing microbial productivity, particularly because natural isolates typically yield commercially valuable products in very low concentrations. Although optimizing the culture medium and environmental conditions can improve yields, these adjustments are inherently limited by the organism’s genetic potential. As a result, the focus shifts toward genetic modifications to enhance biosynthetic capacity. The...
01:25Inducible Operons: lac Operon
The lac operon in Escherichia coli is a model for understanding inducible gene regulation and metabolic flexibility. It integrates local control by lactose and global regulation through catabolite repression, enabling E. coli to preferentially metabolize glucose when available and switch to lactose utilization when glucose is scarce.Structure and Function of the lac OperonThe lac operon contains three structural genes: lacZ (β-galactosidase), lacY (lactose permease), and lacA (thiogalactoside...
01:27Upstream Processing
Upstream processing represents a critical phase in biomanufacturing, wherein biological systems such as microorganisms, mammalian cells, or insect cells are cultivated to produce therapeutic proteins, vaccines, enzymes, or other biologically derived products. This phase encompasses all steps from the selection and genetic manipulation of the production organism to the cultivation of cells in bioreactors under tightly controlled environmental conditions.Host Selection and Genetic OptimizationThe...
01:24Other Glycolytic Pathways
The pentose phosphate pathway (PPP) operates in parallel with glycolysis, facilitating the metabolism of both pentoses and glucose. This pathway consists of two distinct phases: the oxidative and non-oxidative phases. While it does not directly generate ATP, the intermediates formed during the process can integrate into glycolysis, contributing to cellular energy metabolism when required.Oxidative Phase: NADPH ProductionThe oxidative phase of the pentose phosphate pathway is primarily...